Mirador Capital Partners »

Crispr Therapeutics shares owned by Mirador Capital Partners

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Mirador Capital Partners from 13F filings

Historical chart of Mirador Capital Partners investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Mirador Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Mirador Capital Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $203k 3.0k 68.16
2022-12-31 $201k 4.9k 40.65
2022-09-30 $292k 4.5k 65.28
2022-06-30 $256k 4.2k 60.79
2022-03-31 $261k 4.2k 62.79
2021-12-31 $319k 4.2k 75.75